Sitewide
Microarray provides 3 genomic guides to breast cancer treatment decisions
Three genomic tests separately predict the likelihood that a patient's breast cancer will reoccur after surgery without additional treatment, and the cancer's vulnerability to chemotherapy or hormone therapy, researchers at the University of Texas M. D. Anderson Cancer Center report at the first American Society of Clinical Oncology ASCO Breast Cancer Symposium, Sept. 7-8, in San Francisco.
Popular Today:
Similar Articles On This Topic:
- Decision guide reduced uncertainty over breast cancer prevention, study finds
- Genes found linked to breast cancer drug resistance could guide future treatment choices
- New test for breast cancer will help guide treatment choices
- Progress in ultrasound-guided surgery may improve breast cancer treatment
- TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
Science 2.0:
- The Evolved Doubly Social Society Should Be Selfish And Deadly
- Helmet Laws, Not Parental Concern, Have Led To Reduced Fatalities In Bicycle-Car Collisions
- Gorillas And The Future Of Crop Biotechnology
- Could Roadways Actually Be Good For Wildlife?
- Kentucky Windage, For Science: Using Black Holes To Measure The Universe's Rate Of Expansion
Recent Articles:
Create Your Own Releases:
Post new comment